Literature DB >> 21789496

The mantra of mucosal healing.

Joseph H Sellin1.   

Abstract

Year:  2011        PMID： 21789496     DOI： 10.1007/s11894-011-0212-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  11 in total

1.  Infliximab prevents Crohn's disease recurrence after ileal resection.

Authors:  Miguel Regueiro; Wolfgang Schraut; Leonard Baidoo; Kevin E Kip; Antonia R Sepulveda; Marilyn Pesci; Janet Harrison; Scott E Plevy
Journal:  Gastroenterology       Date:  2008-10-31       Impact factor: 22.682

2.  Predictability of the postoperative course of Crohn's disease.

Authors:  P Rutgeerts; K Geboes; G Vantrappen; J Beyls; R Kerremans; M Hiele
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

3.  Clinical significance of inflammatory markers.

Authors:  Bincy P Abraham; Selvi Thirumurthi
Journal:  Curr Gastroenterol Rep       Date:  2009-10

Review 4.  Clinical implications of mucosal healing for the management of IBD.

Authors:  Guillaume Pineton de Chambrun; Laurent Peyrin-Biroulet; Marc Lémann; Jean-Frédéric Colombel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12-01       Impact factor: 46.802

Review 5.  Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.

Authors:  Laurent Peyrin-Biroulet; Pierre Deltenre; Sandro Ardizzone; Geert D'Haens; Stephen B Hanauer; Hans Herfarth; Marc Lémann; Jean-Frédéric Colombel
Journal:  Am J Gastroenterol       Date:  2009-06-30       Impact factor: 10.864

6.  Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.

Authors:  P Rutgeerts; K Geboes; G Vantrappen; R Kerremans; J L Coenegrachts; G Coremans
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

7.  Infliximab for induction and maintenance therapy for ulcerative colitis.

Authors:  Paul Rutgeerts; William J Sandborn; Brian G Feagan; Walter Reinisch; Allan Olson; Jewel Johanns; Suzanne Travers; Daniel Rachmilewitz; Stephen B Hanauer; Gary R Lichtenstein; Willem J S de Villiers; Daniel Present; Bruce E Sands; Jean Frédéric Colombel
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

8.  Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul Rutgeerts; Gert Van Assche; Séverine Vermeire; Geert D'Haens; Filip Baert; Maja Noman; Isolde Aerden; Gert De Hertogh; Karel Geboes; Martin Hiele; Andre D'Hoore; Freddy Penninckx
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

9.  Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease.

Authors:  R S McLeod; B G Wolff; A H Steinhart; P W Carryer; K O'Rourke; D F Andrews; J E Blair; J R Cangemi; Z Cohen; J B Cullen; R G Chaytor; G R Greenberg; N M Jaffer; K N Jeejeebhoy; R L MacCarty; R L Ready; L H Weiland
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

10.  Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease.

Authors:  Dario Sorrentino; Alberto Paviotti; Giovanni Terrosu; Claudio Avellini; Marco Geraci; Dimitra Zarifi
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-04       Impact factor: 11.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.